nodes	percent_of_prediction	percent_of_DWPC	metapath
Labetalol—Visual impairment—Prednisolone—ankylosing spondylitis	0.00354	0.00354	CcSEcCtD
Labetalol—Bradycardia—Triamcinolone—ankylosing spondylitis	0.00344	0.00344	CcSEcCtD
Labetalol—Bradycardia—Methylprednisolone—ankylosing spondylitis	0.00343	0.00343	CcSEcCtD
Labetalol—Hallucination—Methylprednisolone—ankylosing spondylitis	0.00335	0.00335	CcSEcCtD
Labetalol—Anaphylactoid reaction—Methotrexate—ankylosing spondylitis	0.00333	0.00333	CcSEcCtD
Labetalol—Lethargy—Methotrexate—ankylosing spondylitis	0.00329	0.00329	CcSEcCtD
Labetalol—Sweating increased—Prednisone—ankylosing spondylitis	0.00325	0.00325	CcSEcCtD
Labetalol—Visual impairment—Methylprednisolone—ankylosing spondylitis	0.00325	0.00325	CcSEcCtD
Labetalol—Erythema—Prednisolone—ankylosing spondylitis	0.0032	0.0032	CcSEcCtD
Labetalol—Bradycardia—Dexamethasone—ankylosing spondylitis	0.00312	0.00312	CcSEcCtD
Labetalol—Bradycardia—Betamethasone—ankylosing spondylitis	0.00312	0.00312	CcSEcCtD
Labetalol—Erectile dysfunction—Prednisone—ankylosing spondylitis	0.00307	0.00307	CcSEcCtD
Labetalol—Mood swings—Methotrexate—ankylosing spondylitis	0.00305	0.00305	CcSEcCtD
Labetalol—Hallucination—Betamethasone—ankylosing spondylitis	0.00305	0.00305	CcSEcCtD
Labetalol—Hallucination—Dexamethasone—ankylosing spondylitis	0.00305	0.00305	CcSEcCtD
Labetalol—Vision blurred—Prednisolone—ankylosing spondylitis	0.00301	0.00301	CcSEcCtD
Labetalol—Liver function test abnormal—Methotrexate—ankylosing spondylitis	0.00297	0.00297	CcSEcCtD
Labetalol—Ill-defined disorder—Prednisolone—ankylosing spondylitis	0.00296	0.00296	CcSEcCtD
Labetalol—Depression—Prednisone—ankylosing spondylitis	0.00296	0.00296	CcSEcCtD
Labetalol—Visual impairment—Dexamethasone—ankylosing spondylitis	0.00295	0.00295	CcSEcCtD
Labetalol—Visual impairment—Betamethasone—ankylosing spondylitis	0.00295	0.00295	CcSEcCtD
Labetalol—Mental disorder—Methylprednisolone—ankylosing spondylitis	0.00295	0.00295	CcSEcCtD
Labetalol—Erythema—Triamcinolone—ankylosing spondylitis	0.00294	0.00294	CcSEcCtD
Labetalol—Erythema—Methylprednisolone—ankylosing spondylitis	0.00293	0.00293	CcSEcCtD
Labetalol—Angioedema—Prednisolone—ankylosing spondylitis	0.00292	0.00292	CcSEcCtD
Labetalol—Malaise—Prednisolone—ankylosing spondylitis	0.00288	0.00288	CcSEcCtD
Labetalol—Vertigo—Prednisolone—ankylosing spondylitis	0.00287	0.00287	CcSEcCtD
Labetalol—Syncope—Prednisolone—ankylosing spondylitis	0.00287	0.00287	CcSEcCtD
Labetalol—Loss of consciousness—Prednisolone—ankylosing spondylitis	0.00281	0.00281	CcSEcCtD
Labetalol—Hypertension—Prednisolone—ankylosing spondylitis	0.00276	0.00276	CcSEcCtD
Labetalol—Ill-defined disorder—Triamcinolone—ankylosing spondylitis	0.00273	0.00273	CcSEcCtD
Labetalol—Ill-defined disorder—Methylprednisolone—ankylosing spondylitis	0.00272	0.00272	CcSEcCtD
Labetalol—Bradycardia—Prednisone—ankylosing spondylitis	0.00272	0.00272	CcSEcCtD
Labetalol—Alopecia—Betamethasone—ankylosing spondylitis	0.00271	0.00271	CcSEcCtD
Labetalol—Alopecia—Dexamethasone—ankylosing spondylitis	0.00271	0.00271	CcSEcCtD
Labetalol—Discomfort—Prednisolone—ankylosing spondylitis	0.00269	0.00269	CcSEcCtD
Labetalol—Angioedema—Triamcinolone—ankylosing spondylitis	0.00268	0.00268	CcSEcCtD
Labetalol—Angioedema—Methylprednisolone—ankylosing spondylitis	0.00268	0.00268	CcSEcCtD
Labetalol—Erythema—Betamethasone—ankylosing spondylitis	0.00267	0.00267	CcSEcCtD
Labetalol—Erythema—Dexamethasone—ankylosing spondylitis	0.00267	0.00267	CcSEcCtD
Labetalol—Hallucination—Prednisone—ankylosing spondylitis	0.00265	0.00265	CcSEcCtD
Labetalol—Malaise—Triamcinolone—ankylosing spondylitis	0.00265	0.00265	CcSEcCtD
Labetalol—Malaise—Methylprednisolone—ankylosing spondylitis	0.00264	0.00264	CcSEcCtD
Labetalol—Vertigo—Triamcinolone—ankylosing spondylitis	0.00264	0.00264	CcSEcCtD
Labetalol—Syncope—Triamcinolone—ankylosing spondylitis	0.00264	0.00264	CcSEcCtD
Labetalol—Vertigo—Methylprednisolone—ankylosing spondylitis	0.00263	0.00263	CcSEcCtD
Labetalol—Syncope—Methylprednisolone—ankylosing spondylitis	0.00263	0.00263	CcSEcCtD
Labetalol—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.00261	0.00261	CcSEcCtD
Labetalol—Oedema—Prednisolone—ankylosing spondylitis	0.00261	0.00261	CcSEcCtD
Labetalol—Dysuria—Methotrexate—ankylosing spondylitis	0.0026	0.0026	CcSEcCtD
Labetalol—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.00258	0.00258	CcSEcCtD
Labetalol—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.00258	0.00258	CcSEcCtD
Labetalol—Shock—Prednisolone—ankylosing spondylitis	0.00257	0.00257	CcSEcCtD
Labetalol—Erectile dysfunction—Methotrexate—ankylosing spondylitis	0.00256	0.00256	CcSEcCtD
Labetalol—Hypertension—Triamcinolone—ankylosing spondylitis	0.00254	0.00254	CcSEcCtD
Labetalol—Hypertension—Methylprednisolone—ankylosing spondylitis	0.00253	0.00253	CcSEcCtD
Labetalol—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.00252	0.00252	CcSEcCtD
Labetalol—Drowsiness—Methotrexate—ankylosing spondylitis	0.00248	0.00248	CcSEcCtD
Labetalol—Depression—Methotrexate—ankylosing spondylitis	0.00248	0.00248	CcSEcCtD
Labetalol—Flushing—Prednisone—ankylosing spondylitis	0.00248	0.00248	CcSEcCtD
Labetalol—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.00247	0.00247	CcSEcCtD
Labetalol—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.00247	0.00247	CcSEcCtD
Labetalol—Discomfort—Triamcinolone—ankylosing spondylitis	0.00247	0.00247	CcSEcCtD
Labetalol—Discomfort—Methylprednisolone—ankylosing spondylitis	0.00247	0.00247	CcSEcCtD
Labetalol—Angioedema—Dexamethasone—ankylosing spondylitis	0.00244	0.00244	CcSEcCtD
Labetalol—Angioedema—Betamethasone—ankylosing spondylitis	0.00244	0.00244	CcSEcCtD
Labetalol—Confusional state—Methylprednisolone—ankylosing spondylitis	0.00241	0.00241	CcSEcCtD
Labetalol—Malaise—Dexamethasone—ankylosing spondylitis	0.0024	0.0024	CcSEcCtD
Labetalol—Malaise—Betamethasone—ankylosing spondylitis	0.0024	0.0024	CcSEcCtD
Labetalol—Oedema—Triamcinolone—ankylosing spondylitis	0.0024	0.0024	CcSEcCtD
Labetalol—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.0024	0.0024	CcSEcCtD
Labetalol—Vertigo—Betamethasone—ankylosing spondylitis	0.0024	0.0024	CcSEcCtD
Labetalol—Vertigo—Dexamethasone—ankylosing spondylitis	0.0024	0.0024	CcSEcCtD
Labetalol—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.00239	0.00239	CcSEcCtD
Labetalol—Syncope—Dexamethasone—ankylosing spondylitis	0.00239	0.00239	CcSEcCtD
Labetalol—Syncope—Betamethasone—ankylosing spondylitis	0.00239	0.00239	CcSEcCtD
Labetalol—Sweating—Methotrexate—ankylosing spondylitis	0.00238	0.00238	CcSEcCtD
Labetalol—Shock—Triamcinolone—ankylosing spondylitis	0.00236	0.00236	CcSEcCtD
Labetalol—Alopecia—Prednisone—ankylosing spondylitis	0.00236	0.00236	CcSEcCtD
Labetalol—Shock—Methylprednisolone—ankylosing spondylitis	0.00235	0.00235	CcSEcCtD
Labetalol—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.00234	0.00234	CcSEcCtD
Labetalol—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.00234	0.00234	CcSEcCtD
Labetalol—Epistaxis—Methotrexate—ankylosing spondylitis	0.00234	0.00234	CcSEcCtD
Labetalol—Paraesthesia—Prednisolone—ankylosing spondylitis	0.00234	0.00234	CcSEcCtD
Labetalol—Mental disorder—Prednisone—ankylosing spondylitis	0.00234	0.00234	CcSEcCtD
Labetalol—Erythema—Prednisone—ankylosing spondylitis	0.00232	0.00232	CcSEcCtD
Labetalol—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.00232	0.00232	CcSEcCtD
Labetalol—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.00232	0.00232	CcSEcCtD
Labetalol—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.00231	0.00231	CcSEcCtD
Labetalol—Hypertension—Betamethasone—ankylosing spondylitis	0.0023	0.0023	CcSEcCtD
Labetalol—Hypertension—Dexamethasone—ankylosing spondylitis	0.0023	0.0023	CcSEcCtD
Labetalol—Discomfort—Betamethasone—ankylosing spondylitis	0.00224	0.00224	CcSEcCtD
Labetalol—Discomfort—Dexamethasone—ankylosing spondylitis	0.00224	0.00224	CcSEcCtD
Labetalol—Hypotension—Methylprednisolone—ankylosing spondylitis	0.00224	0.00224	CcSEcCtD
Labetalol—Pain—Prednisolone—ankylosing spondylitis	0.00223	0.00223	CcSEcCtD
Labetalol—Hepatitis—Methotrexate—ankylosing spondylitis	0.00223	0.00223	CcSEcCtD
Labetalol—Vision blurred—Prednisone—ankylosing spondylitis	0.00219	0.00219	CcSEcCtD
Labetalol—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.00218	0.00218	CcSEcCtD
Labetalol—Oedema—Dexamethasone—ankylosing spondylitis	0.00218	0.00218	CcSEcCtD
Labetalol—Oedema—Betamethasone—ankylosing spondylitis	0.00218	0.00218	CcSEcCtD
Labetalol—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.00218	0.00218	CcSEcCtD
Labetalol—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.00215	0.00215	CcSEcCtD
Labetalol—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.00215	0.00215	CcSEcCtD
Labetalol—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.00215	0.00215	CcSEcCtD
Labetalol—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.00215	0.00215	CcSEcCtD
Labetalol—Visual impairment—Methotrexate—ankylosing spondylitis	0.00215	0.00215	CcSEcCtD
Labetalol—Shock—Betamethasone—ankylosing spondylitis	0.00214	0.00214	CcSEcCtD
Labetalol—Shock—Dexamethasone—ankylosing spondylitis	0.00214	0.00214	CcSEcCtD
Labetalol—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.00214	0.00214	CcSEcCtD
Labetalol—Angioedema—Prednisone—ankylosing spondylitis	0.00212	0.00212	CcSEcCtD
Labetalol—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.00211	0.00211	CcSEcCtD
Labetalol—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.00211	0.00211	CcSEcCtD
Labetalol—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.0021	0.0021	CcSEcCtD
Labetalol—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.0021	0.0021	CcSEcCtD
Labetalol—Malaise—Prednisone—ankylosing spondylitis	0.00209	0.00209	CcSEcCtD
Labetalol—Vertigo—Prednisone—ankylosing spondylitis	0.00209	0.00209	CcSEcCtD
Labetalol—Syncope—Prednisone—ankylosing spondylitis	0.00208	0.00208	CcSEcCtD
Labetalol—Urticaria—Prednisolone—ankylosing spondylitis	0.00207	0.00207	CcSEcCtD
Labetalol—Fatigue—Triamcinolone—ankylosing spondylitis	0.00207	0.00207	CcSEcCtD
Labetalol—Fatigue—Methylprednisolone—ankylosing spondylitis	0.00206	0.00206	CcSEcCtD
Labetalol—Pain—Triamcinolone—ankylosing spondylitis	0.00205	0.00205	CcSEcCtD
Labetalol—Loss of consciousness—Prednisone—ankylosing spondylitis	0.00204	0.00204	CcSEcCtD
Labetalol—Hypotension—Dexamethasone—ankylosing spondylitis	0.00203	0.00203	CcSEcCtD
Labetalol—Hypotension—Betamethasone—ankylosing spondylitis	0.00203	0.00203	CcSEcCtD
Labetalol—Hypertension—Prednisone—ankylosing spondylitis	0.002	0.002	CcSEcCtD
Labetalol—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.00198	0.00198	CcSEcCtD
Labetalol—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.00197	0.00197	CcSEcCtD
Labetalol—Alopecia—Methotrexate—ankylosing spondylitis	0.00197	0.00197	CcSEcCtD
Labetalol—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.00196	0.00196	CcSEcCtD
Labetalol—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.00195	0.00195	CcSEcCtD
Labetalol—Paraesthesia—Betamethasone—ankylosing spondylitis	0.00195	0.00195	CcSEcCtD
Labetalol—Discomfort—Prednisone—ankylosing spondylitis	0.00195	0.00195	CcSEcCtD
Labetalol—Mental disorder—Methotrexate—ankylosing spondylitis	0.00195	0.00195	CcSEcCtD
Labetalol—Erythema—Methotrexate—ankylosing spondylitis	0.00194	0.00194	CcSEcCtD
Labetalol—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.00192	0.00192	CcSEcCtD
Labetalol—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.00192	0.00192	CcSEcCtD
Labetalol—Dyspepsia—Betamethasone—ankylosing spondylitis	0.00192	0.00192	CcSEcCtD
Labetalol—Urticaria—Triamcinolone—ankylosing spondylitis	0.00191	0.00191	CcSEcCtD
Labetalol—Urticaria—Methylprednisolone—ankylosing spondylitis	0.0019	0.0019	CcSEcCtD
Labetalol—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.0019	0.0019	CcSEcCtD
Labetalol—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.0019	0.0019	CcSEcCtD
Labetalol—Oedema—Prednisone—ankylosing spondylitis	0.0019	0.0019	CcSEcCtD
Labetalol—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.00189	0.00189	CcSEcCtD
Labetalol—Fatigue—Dexamethasone—ankylosing spondylitis	0.00188	0.00188	CcSEcCtD
Labetalol—Fatigue—Betamethasone—ankylosing spondylitis	0.00188	0.00188	CcSEcCtD
Labetalol—Shock—Prednisone—ankylosing spondylitis	0.00186	0.00186	CcSEcCtD
Labetalol—Pain—Betamethasone—ankylosing spondylitis	0.00186	0.00186	CcSEcCtD
Labetalol—Pain—Dexamethasone—ankylosing spondylitis	0.00186	0.00186	CcSEcCtD
Labetalol—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.00183	0.00183	CcSEcCtD
Labetalol—Vision blurred—Methotrexate—ankylosing spondylitis	0.00183	0.00183	CcSEcCtD
Labetalol—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.0018	0.0018	CcSEcCtD
Labetalol—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.00179	0.00179	CcSEcCtD
Labetalol—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.00179	0.00179	CcSEcCtD
Labetalol—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.00178	0.00178	CcSEcCtD
Labetalol—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.00178	0.00178	CcSEcCtD
Labetalol—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.00177	0.00177	CcSEcCtD
Labetalol—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.00176	0.00176	CcSEcCtD
Labetalol—Malaise—Methotrexate—ankylosing spondylitis	0.00175	0.00175	CcSEcCtD
Labetalol—Vertigo—Methotrexate—ankylosing spondylitis	0.00174	0.00174	CcSEcCtD
Labetalol—Urticaria—Dexamethasone—ankylosing spondylitis	0.00173	0.00173	CcSEcCtD
Labetalol—Urticaria—Betamethasone—ankylosing spondylitis	0.00173	0.00173	CcSEcCtD
Labetalol—Dizziness—Prednisolone—ankylosing spondylitis	0.00172	0.00172	CcSEcCtD
Labetalol—Asthenia—Triamcinolone—ankylosing spondylitis	0.00172	0.00172	CcSEcCtD
Labetalol—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.00172	0.00172	CcSEcCtD
Labetalol—Abdominal pain—Betamethasone—ankylosing spondylitis	0.00172	0.00172	CcSEcCtD
Labetalol—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.00172	0.00172	CcSEcCtD
Labetalol—Body temperature increased—Betamethasone—ankylosing spondylitis	0.00172	0.00172	CcSEcCtD
Labetalol—Asthenia—Methylprednisolone—ankylosing spondylitis	0.00172	0.00172	CcSEcCtD
Labetalol—Paraesthesia—Prednisone—ankylosing spondylitis	0.0017	0.0017	CcSEcCtD
Labetalol—Pruritus—Triamcinolone—ankylosing spondylitis	0.0017	0.0017	CcSEcCtD
Labetalol—Pruritus—Methylprednisolone—ankylosing spondylitis	0.00169	0.00169	CcSEcCtD
Labetalol—Dyspepsia—Prednisone—ankylosing spondylitis	0.00167	0.00167	CcSEcCtD
Labetalol—Rash—Prednisolone—ankylosing spondylitis	0.00164	0.00164	CcSEcCtD
Labetalol—Dermatitis—Prednisolone—ankylosing spondylitis	0.00164	0.00164	CcSEcCtD
Labetalol—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00164	0.00164	CcSEcCtD
Labetalol—Fatigue—Prednisone—ankylosing spondylitis	0.00163	0.00163	CcSEcCtD
Labetalol—Headache—Prednisolone—ankylosing spondylitis	0.00163	0.00163	CcSEcCtD
Labetalol—Discomfort—Methotrexate—ankylosing spondylitis	0.00163	0.00163	CcSEcCtD
Labetalol—Constipation—Prednisone—ankylosing spondylitis	0.00162	0.00162	CcSEcCtD
Labetalol—Confusional state—Methotrexate—ankylosing spondylitis	0.0016	0.0016	CcSEcCtD
Labetalol—Dizziness—Triamcinolone—ankylosing spondylitis	0.00159	0.00159	CcSEcCtD
Labetalol—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.00158	0.00158	CcSEcCtD
Labetalol—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00158	0.00158	CcSEcCtD
Labetalol—Feeling abnormal—Prednisone—ankylosing spondylitis	0.00156	0.00156	CcSEcCtD
Labetalol—Asthenia—Dexamethasone—ankylosing spondylitis	0.00156	0.00156	CcSEcCtD
Labetalol—Asthenia—Betamethasone—ankylosing spondylitis	0.00156	0.00156	CcSEcCtD
Labetalol—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.00155	0.00155	CcSEcCtD
Labetalol—Nausea—Prednisolone—ankylosing spondylitis	0.00155	0.00155	CcSEcCtD
Labetalol—Pruritus—Dexamethasone—ankylosing spondylitis	0.00154	0.00154	CcSEcCtD
Labetalol—Pruritus—Betamethasone—ankylosing spondylitis	0.00154	0.00154	CcSEcCtD
Labetalol—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.00153	0.00153	CcSEcCtD
Labetalol—Vomiting—Triamcinolone—ankylosing spondylitis	0.00152	0.00152	CcSEcCtD
Labetalol—Vomiting—Methylprednisolone—ankylosing spondylitis	0.00152	0.00152	CcSEcCtD
Labetalol—Rash—Triamcinolone—ankylosing spondylitis	0.00151	0.00151	CcSEcCtD
Labetalol—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00151	0.00151	CcSEcCtD
Labetalol—Rash—Methylprednisolone—ankylosing spondylitis	0.00151	0.00151	CcSEcCtD
Labetalol—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.00151	0.00151	CcSEcCtD
Labetalol—Urticaria—Prednisone—ankylosing spondylitis	0.00151	0.00151	CcSEcCtD
Labetalol—Headache—Triamcinolone—ankylosing spondylitis	0.0015	0.0015	CcSEcCtD
Labetalol—Headache—Methylprednisolone—ankylosing spondylitis	0.0015	0.0015	CcSEcCtD
Labetalol—Body temperature increased—Prednisone—ankylosing spondylitis	0.0015	0.0015	CcSEcCtD
Labetalol—Abdominal pain—Prednisone—ankylosing spondylitis	0.0015	0.0015	CcSEcCtD
Labetalol—Diarrhoea—Betamethasone—ankylosing spondylitis	0.00149	0.00149	CcSEcCtD
Labetalol—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.00149	0.00149	CcSEcCtD
Labetalol—Hypotension—Methotrexate—ankylosing spondylitis	0.00148	0.00148	CcSEcCtD
Labetalol—Dizziness—Dexamethasone—ankylosing spondylitis	0.00144	0.00144	CcSEcCtD
Labetalol—Dizziness—Betamethasone—ankylosing spondylitis	0.00144	0.00144	CcSEcCtD
Labetalol—Nausea—Triamcinolone—ankylosing spondylitis	0.00142	0.00142	CcSEcCtD
Labetalol—Paraesthesia—Methotrexate—ankylosing spondylitis	0.00142	0.00142	CcSEcCtD
Labetalol—Nausea—Methylprednisolone—ankylosing spondylitis	0.00142	0.00142	CcSEcCtD
Labetalol—Dyspnoea—Methotrexate—ankylosing spondylitis	0.00141	0.00141	CcSEcCtD
Labetalol—Somnolence—Methotrexate—ankylosing spondylitis	0.00141	0.00141	CcSEcCtD
Labetalol—Hypersensitivity—Prednisone—ankylosing spondylitis	0.0014	0.0014	CcSEcCtD
Labetalol—Dyspepsia—Methotrexate—ankylosing spondylitis	0.00139	0.00139	CcSEcCtD
Labetalol—Vomiting—Betamethasone—ankylosing spondylitis	0.00138	0.00138	CcSEcCtD
Labetalol—Vomiting—Dexamethasone—ankylosing spondylitis	0.00138	0.00138	CcSEcCtD
Labetalol—Rash—Dexamethasone—ankylosing spondylitis	0.00137	0.00137	CcSEcCtD
Labetalol—Rash—Betamethasone—ankylosing spondylitis	0.00137	0.00137	CcSEcCtD
Labetalol—Dermatitis—Betamethasone—ankylosing spondylitis	0.00137	0.00137	CcSEcCtD
Labetalol—Dermatitis—Dexamethasone—ankylosing spondylitis	0.00137	0.00137	CcSEcCtD
Labetalol—Fatigue—Methotrexate—ankylosing spondylitis	0.00137	0.00137	CcSEcCtD
Labetalol—Headache—Betamethasone—ankylosing spondylitis	0.00136	0.00136	CcSEcCtD
Labetalol—Headache—Dexamethasone—ankylosing spondylitis	0.00136	0.00136	CcSEcCtD
Labetalol—Asthenia—Prednisone—ankylosing spondylitis	0.00136	0.00136	CcSEcCtD
Labetalol—Pain—Methotrexate—ankylosing spondylitis	0.00135	0.00135	CcSEcCtD
Labetalol—Pruritus—Prednisone—ankylosing spondylitis	0.00134	0.00134	CcSEcCtD
Labetalol—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.00131	0.00131	CcSEcCtD
Labetalol—Diarrhoea—Prednisone—ankylosing spondylitis	0.0013	0.0013	CcSEcCtD
Labetalol—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.0013	0.0013	CcSEcCtD
Labetalol—Nausea—Dexamethasone—ankylosing spondylitis	0.00129	0.00129	CcSEcCtD
Labetalol—Nausea—Betamethasone—ankylosing spondylitis	0.00129	0.00129	CcSEcCtD
Labetalol—Urticaria—Methotrexate—ankylosing spondylitis	0.00126	0.00126	CcSEcCtD
Labetalol—Dizziness—Prednisone—ankylosing spondylitis	0.00125	0.00125	CcSEcCtD
Labetalol—Abdominal pain—Methotrexate—ankylosing spondylitis	0.00125	0.00125	CcSEcCtD
Labetalol—Body temperature increased—Methotrexate—ankylosing spondylitis	0.00125	0.00125	CcSEcCtD
Labetalol—Vomiting—Prednisone—ankylosing spondylitis	0.0012	0.0012	CcSEcCtD
Labetalol—Rash—Prednisone—ankylosing spondylitis	0.00119	0.00119	CcSEcCtD
Labetalol—Dermatitis—Prednisone—ankylosing spondylitis	0.00119	0.00119	CcSEcCtD
Labetalol—Headache—Prednisone—ankylosing spondylitis	0.00119	0.00119	CcSEcCtD
Labetalol—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.00117	0.00117	CcSEcCtD
Labetalol—Asthenia—Methotrexate—ankylosing spondylitis	0.00114	0.00114	CcSEcCtD
Labetalol—Nausea—Prednisone—ankylosing spondylitis	0.00113	0.00113	CcSEcCtD
Labetalol—Pruritus—Methotrexate—ankylosing spondylitis	0.00112	0.00112	CcSEcCtD
Labetalol—Diarrhoea—Methotrexate—ankylosing spondylitis	0.00108	0.00108	CcSEcCtD
Labetalol—Dizziness—Methotrexate—ankylosing spondylitis	0.00105	0.00105	CcSEcCtD
Labetalol—Vomiting—Methotrexate—ankylosing spondylitis	0.00101	0.00101	CcSEcCtD
Labetalol—Rash—Methotrexate—ankylosing spondylitis	0.000999	0.000999	CcSEcCtD
Labetalol—Dermatitis—Methotrexate—ankylosing spondylitis	0.000998	0.000998	CcSEcCtD
Labetalol—Headache—Methotrexate—ankylosing spondylitis	0.000992	0.000992	CcSEcCtD
Labetalol—Nausea—Methotrexate—ankylosing spondylitis	0.000941	0.000941	CcSEcCtD
